Blaise R. Kimmel

Blaise R. Kimmel's work sits at the intersection of protein/enzyme engineering, nanomaterials, and cancer immunotherapy. Recent publications focus on engineering nanoparticles and polymer-drug conjugates that activate immune-signaling pathways (like STING and RIG-I) to fight cancer, as well as developing tools such as yeast display platforms and non-canonical amino acids to build and screen new proteins and antibody-like molecules. Much of the research combines chemistry, molecular biology, and materials science to create delivery systems and diagnostic or therapeutic biomolecules.

Publication output has grown substantially over the last decade, rising from occasional single papers in 2017-2019 to a much higher and still increasing pace (5-8+ papers per year) by 2024-2026.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026